Boston Scientific Current Ratio 2006-2018 | BSX

Current and historical current ratio for Boston Scientific (BSX) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Boston Scientific current ratio for the three months ending September 30, 2018 was 0.78.
Boston Scientific Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $3.97B $5.08B 0.78
2018-06-30 $3.93B $4.75B 0.83
2018-03-31 $4.08B $4.99B 0.82
2017-12-31 $3.82B $5.65B 0.68
2017-09-30 $3.48B $4.83B 0.72
2017-06-30 $3.22B $4.30B 0.75
2017-03-31 $3.03B $3.49B 0.87
2016-12-31 $3.24B $3.59B 0.90
2016-09-30 $3.18B $3.02B 1.06
2016-06-30 $3.33B $3.18B 1.05
2016-03-31 $3.16B $2.61B 1.21
2015-12-31 $3.47B $2.43B 1.43
2015-09-30 $3.46B $2.24B 1.55
2015-06-30 $3.77B $1.94B 1.95
2015-03-31 $3.19B $2.46B 1.30
2014-12-31 $3.61B $2.85B 1.27
2014-09-30 $3.18B $1.82B 1.75
2014-06-30 $3.21B $1.77B 1.81
2014-03-31 $2.94B $1.72B 1.71
2013-12-31 $3.01B $1.82B 1.65
2013-09-30 $3.53B $1.90B 1.85
2013-06-30 $3.50B $2.48B 1.41
2013-03-31 $3.10B $1.64B 1.90
2012-12-31 $3.02B $1.77B 1.71
2012-09-30 $3.17B $1.82B 1.75
2012-06-30 $3.11B $1.79B 1.73
2012-03-31 $3.09B $1.67B 1.85
2011-12-31 $3.11B $1.81B 1.72
2011-09-30 $3.21B $1.89B 1.70
2011-06-30 $3.15B $1.89B 1.66
2011-03-31 $3.57B $2.04B 1.75
2010-12-31 $3.62B $2.61B 1.39
2010-09-30 $3.56B $2.96B 1.20
2010-06-30 $3.99B $3.72B 1.07
2010-03-31 $3.75B $2.91B 1.29
2009-12-31 $4.60B $3.02B 1.52
2009-09-30 $4.96B $3.18B 1.56
2009-06-30 $4.80B $2.75B 1.74
2009-03-31 $4.57B $2.43B 1.88
2008-12-31 $5.45B $3.23B 1.69
2008-09-30 $5.29B $3.54B 1.49
2008-06-30 $5.17B $3.04B 1.70
2008-03-31 $5.24B $3.39B 1.55
2007-12-31 $5.94B $3.25B 1.83
2007-09-30 $4.69B $3.38B 1.39
2007-06-30 $4.94B $2.97B 1.66
2007-03-31 $4.58B $2.37B 1.93
2006-12-31 $6.03B $2.63B 2.29
2006-09-30 $4.75B $2.45B 1.94
2006-06-30 $4.41B $2.17B 2.03
2006-03-31 $2.87B $2.04B 1.41
2005-12-31 $2.63B $1.48B 1.78
2005-09-30 $2.76B $1.14B 2.42
2005-06-30 $2.72B $1.76B 1.55
2005-03-31 $2.76B $1.78B 1.55
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.540B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $125.870B 18.82
Abbott Laboratories (ABT) United States $124.278B 25.18
Stryker (SYK) United States $62.325B 23.49
Baxter (BAX) United States $34.962B 22.58
Zimmer Biomet Holdings (ZBH) United States $22.231B 14.42
Smith & Nephew SNATS (SNN) United Kingdom $16.467B 0.00
ResMed (RMD) United States $16.093B 30.69
Perrigo (PRGO) Ireland $7.742B 11.75
Bio-Rad Laboratories (BIO) United States $7.425B 47.47
Canopy Growth (CGC) Canada $7.178B 0.00
Hill-Rom Holdings (HRC) United States $6.230B 19.49
Aurora Cannabis (ACB) Canada $5.840B 30.84
Haemonetics (HAE) United States $5.316B 46.75
Insulet (PODD) United States $4.707B 0.00
ICU Medical (ICUI) United States $4.538B 25.28
Hutchison China MediTech (HCM) China $4.506B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.605B 0.00
Neogen (NEOG) United States $3.236B 49.00
Agios Pharmaceuticals (AGIO) United States $2.998B 0.00
NuVasive (NUVA) United States $2.834B 26.37
National Vision Holdings (EYE) United States $2.303B 44.54
Quidel (QDEL) United States $1.963B 25.59
NxStage Medical (NXTM) United States $1.895B 0.00
Aphria (APHA) $1.399B 0.00
Phibro Animal Health (PAHC) United States $1.330B 18.83
AtriCure (ATRC) United States $1.135B 0.00
Cardiovascular Systems (CSII) United States $0.971B 1397.50
VAREX IMAGING (VREX) United States $0.893B 17.88
PetIQ (PETQ) United States $0.841B 21.79
Cerus (CERS) United States $0.750B 0.00
Meridian Bioscience (VIVO) United States $0.741B 23.61
Surmodics (SRDX) United States $0.740B 112.69
OraSure Technologies (OSUR) United States $0.701B 39.48
Lantheus Holdings (LNTH) United States $0.665B 20.58
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.02
Omeros (OMER) United States $0.651B 0.00
MacroGenics (MGNX) United States $0.579B 0.00
NanoString Technologies (NSTG) United States $0.506B 0.00
LeMaitre Vascular (LMAT) United States $0.488B 23.95
Quanterix (QTRX) United States $0.409B 0.00
Owens & Minor (OMI) United States $0.402B 4.55
TG Therapeutics (TGTX) United States $0.394B 0.00
Insys Therapeutics (INSY) United States $0.365B 0.00
Evolus (EOLS) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.317B 20.51
VAPOTHERM INC (VAPO) United States $0.303B 0.00
Cytosorbents (CTSO) United States $0.287B 0.00
Surface Oncology (SURF) United States $0.228B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.225B 0.00
BioLife Solutions (BLFS) United States $0.205B 277.25
Rockwell Medical (RMTI) United States $0.179B 0.00
Chimerix (CMRX) United States $0.165B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.136B 0.00
Fonar (FONR) United States $0.134B 6.75
Chembio Diagnostics (CEMI) United States $0.103B 0.00
Female Health (VERU) United States $0.085B 0.00
United-Guardian (UG) United States $0.079B 16.63
Oramed Pharmaceuticals (ORMP) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 17.27
CAS Medical Systems (CASM) United States $0.050B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.032B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Senestech (SNES) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00